Skip to content

Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers

Tailored Tobacco Intervention

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01892813
Enrollment
411
Registered
2013-07-04
Start date
2013-07-31
Completion date
2018-01-31
Last updated
2017-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Dependence, Tobacco Use

Keywords

Nicotine dependence, Smoking cessation, Telehealth, Alcohol use, Depression, Body weight

Brief summary

The project is designed to examine the effectiveness of strategies to increase access to treatment for tobacco use and dependence among rural Veteran smokers. In addition, it will examine whether tailored treatment that is designed to address common comorbid conditions that are related to cigarette smoking enhances success with quitting relative to enhanced standard of care. The investigators hypothesize that participants assigned to the tailored tobacco cessation intervention will report greater cessation rates at six months. The investigators also anticipate more favorable outcomes on measures of depressive symptoms, alcohol use, and body weight.

Interventions

Medication selection will be determined based on individual participant preferences, medical history, and contraindications.

Medication selection will be determined based on individual participant preferences, medical history, and contraindications.

Medication selection will be determined based on individual participant preferences, medical history, and contraindications.

DRUGBupropion

Medication selection will be determined based on individual participant preferences, medical history, and contraindications.

DRUGVarenicline

Medication selection will be determined based on individual participant preferences, medical history, and contraindications.

Medication selection will be determined based on individual participant preferences, medical history, and contraindications.

Medication selection will be determined based on individual participant preferences, medical history, and contraindications.

Medication selection will be determined based on individual participant preferences, medical history, and contraindications.

BEHAVIORALTobacco quitline referral

Participants assigned to this condition will receive a referral to their state tobacco quitline. The specific behavioral treatment that is provided will differ slightly depending upon the services available through the participant's state of residence.

Participants will receive a standard six session cognitive behavioral intervention for smoking cessation combined with supplemental treatment modules based on individual need and preference.

Participants engaging in risky alcohol use may receive this six-session telephone-based behavioral intervention for reducing alcohol use.

BEHAVIORALBehavioral activation for depressive symptoms

Participants with elevated depressive symptoms may receive this six-session telephone-based behavioral activation intervention.

BEHAVIORALBehavioral management of postcessation weight gain

Participants with concerns about gaining weight after quitting smoking may receive this six-session telephone-based behavioral self-management intervention designed to help attenuate post-cessation weight gain.

Sponsors

VA Office of Research and Development
CollaboratorFED
Mark Vander Weg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

* Veteran status * 18 + years of age * Smoke cigarettes on at least a daily basis * Receive primary care from the Iowa City VA Health Care System or an affiliated Community-based Outpatient Clinic (CBOC) * Live in a non-metropolitan area (based on Rural-Urban Commuting Area Codes (RUCA) codes) * Be willing to make an attempt to quit smoking in the next 30 days * Be capable of providing informed consent * Have access to a telephone (land line or cell phone) * Have a stable residence

Exclusion criteria

* Planning to move within the next 12 months * Presence of a terminal illness * Pregnancy * Unstable psychiatric disorder (e.g., acute psychosis) * Currently pregnant * Incarcerated * Institutionalized

Design outcomes

Primary

MeasureTime frameDescription
Tobacco useSix-month follow-upAt the six-month follow-up contact, participants will be questioned regarding self-reported tobacco use over the past seven and 30 days.

Secondary

MeasureTime frameDescription
Alcohol useSix-month follow-upAlcohol use during the previous seven days will be assessed at the six month follow-up. Based on this information, several metrics of alcohol consumption will be obtained including: 1) average number of drinking days per week, 2) average number of drinks per drinking day, 3) number of drinks per week 4) number of heavy drinking days, and 5) maximum drinks consumed on a single occasion.
Depressive symptomsSix-month follow-upDepressive symptoms will be assessed at the six-month follow-up using the Patient Health Questionnaire 9 (PHQ-9).
Body weightSix-month follow-upChange in body weight will be assessed via self-report and chart review at the six-month follow-up.
Physical ActivitySix-month follow-upPhysical activity will be assessed by self-report at the six-month follow-up visit using the Rapid Assessment of Physical Activity (RAPA).
Dietary intakeSix-month follow-upSelf-reported dietary intake will be measured at six months using the Starting the Conversation - Diet questionnaire.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026